Uncategorized

Uncategorized

Programs For Purchase

Program 1 HEALTH TECHNOLOGY ASESSMENT REBUILT: EVIDENCE AND VALUE A MEASUREMENT BASED INTERROGATION USING AI AND LARGE LANGUAGE MODELS UNIT 1: FOUNDATIONS OF MEASUREMENT IN SCIENCE – 4 MODULES MODULE 1: ATTRIBUTES AND THE LOGIC OF MEASUREMENT MODULE 2: SCALES OF MEASUREMENT AND DIMENSIONAL HOMOGENEITY MODULE 3: THE AXIOMS AND THEOREMS  OF REPRESENTATIONAL MEASUREMENT MODULE 4: REPRESENTATIONAL MEASUREMENT AND LARGE LANGUAGE MODELS UNIT 2: FOUNDATIONS OF MEASUREMENT IN SCIENCE – 4 MODULES MODULE 5: CHEERS 2022 – THE FLAGSHIP OF MEASUREMENT FAILURE

Read More
Uncategorized

THE PATIENT VOICE: ADVOCACY AND SUPPORT

Maimon Research LLC has a long standing advisory and consulting relationship with a leading patient advocacy and support group: Patients Rising and Patients Rising Now. Under the direction of Ms Terry Wilcox, Patients Rising is focused on advocacy and support for access to quality affordable healthcare while Patients Rising Now is focused on advocacy and support for the rights of patients with chronic and life threatening diseases. For more information on current activities, the links are www.patientsrising.org and www.patientsrisingnow.org

Read More
Uncategorized

Publications 2015-2019

Langley PC. The status of modeled claims (Editorial). J Med Econ. 2015;18(12):991-2 https://www.tandfonline.com/doi/full/10.3111/13696998.2015.1108920 Langley PC. Validation of modeled pharmacoeconomic claims in formulary submissions, J Med Econ. 2015;18(12):993-99 https://pubmed.ncbi.nlm.nih.gov/26549802/ Langley PC. Imaginary Worlds: Reproducibility and Modeled Claims in Precision Medicine. J Precision Medicine. 2016; March/April:17-22 Langley PC. Na domhain shamhlaíochta: formulary submission guidelines in Ireland and the standards of normal science. Curr Med Res Opin. 2016;32(5):DOI:10.1080/03007995.2016.1190699 https://www.tandfonline.com/doi/full/10.1080/03007995.2016.1190699#abstract Langley PC.  Imaginary worlds: Modeled claims for cost-effectiveness published in PharmacoEconomics January 2015 to December 2015.

Read More